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Abstract
Background: Primary Sjo¨gren syndrome (pSS) is an autoimmune disorder characterized by exocrine gland and extraglandular symptoms. We present a case
report of pSS with an initial presentation of athetoid movements.
Case Report: A 74-year-old female presented with a 2-month history of slow undulating movements in her trunk and thighs that eventually spread to her neck
and lower extremities. She also reported dry eyes, dry mouth, as well as pain in her shoulders and thighs. Her proinflammatory markers and rheumatologic profile
were positive. Her salivary gland biopsy revealed a Focus score . 2. Brain magnetic resonance imaging was normal. A diagnosis of pSS was made. The patient’s
symptoms improved with hydroxychloroquine, pilocarpine, gabapentin, and clonazepam.
Discussion: Clinicians should consider and screen for primary autoimmune disorders as a cause of subacute athetoid movements in elderly patients. Although
aggressive treatment has been recommended, treatment should be tailored to each patient’s specific needs.
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Introduction
Primary Sjo¨gren syndrome (pSS) is a systemic autoimmune disorder
that impairs exocrine gland function and is associated with extra-
glandular manifestations. The central and peripheral nervous system is
involved in 15% of cases. The most commonly reported neurological
extraglandular manifestations are sensory polyneuropathies. Only 2%
of pSS patients have been reported to develop movement disorders.1
We present a case of pSS that initially presented with athetoid
movements.
Case report
A 74-year-old female with a history of hypothyroidism, treated
with levothyroxine, presented to the clinic with a 2-month history
of involuntary movements. The movements developed slowly over a
couple of days. They involved her trunk and thighs, and then spread
to her neck and lower extremities over the following weeks. The
movements were associated with neck, shoulder, and thigh pain.
The movements were functionally and socially impairing with no
aggravating or relieving factors reported. Movement did not relieve
the associated pain and there was no sense of urgency reported with
the movements. She noted the ability to suppress the movements at
times. She also reported the presence of dry eyes and mouth over the
previous 6–8 weeks. Her physical examination exhibited globally
decreased reflexes. Her movements were described as slow, undulating
movements of the trunk and legs, which moved and rotated from one
side to the other in a non-specific pattern. The movements were only
present during rest, either when sitting or lying down and were more
intense when lying down. They did not interfere with walking and
were absent during sleep (Video 1). The remainder of the neurological
examination was unremarkable.
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Toxic/metabolic and infectious causes were ruled out. A magnetic
resonance imaging (MRI) brain scan, electroencephalogram, nerve
conduction studies (NCS), and electromyography of all four extremities
revealed no abnormalities.
A contrasted thoracic–abdominal–pelvic computed tomography scan
was normal. Her proinflammatory markers showed highly abnormal
acute-phase markers. In addition, her autoimmune profile was positive
for antinuclear antibodies (1:640 mottled/spiculated), anti-Ro/SS-A
(22.9 U/mL, negative ,12 U/mL), rheumatoid factor (immunoglo-
bulin M .200.0 U/mL, negative ,6 U/mL), anti-topoisomerase I
(29.67 U/mL, negative,32 U/mL), and anticentromere (141.48 U/mL,
negative,50 U/mL). A paraneoplastic panel was negative. A Schirmer’s
test revealed ,3 mm and ,4 mm of moisture in the left and right eye,
respectively. Her salivary gland biopsy showed sialadenitis with a
Focus score .2. Lumbar puncture revealed no cells, normal glucose
and protein, with positive oligoclonal bands. A diagnosis of pSS
was made according to the 2016 American College of Rheumatology/
European League Against Rheumatism (ACR/EULAR) criteria. Treat-
ment was started with hydroxychloroquine, 200 mg per day; pilocarpine,
5 mg per day; gabapentin, 300 mg per day; and clonazepam, 0.5 mg per
day. At the 6-month follow-up, the patient reported 90% improvement of
symptoms. The frequency of athetoid movements decreased substantially
to a frequency of one or two events per month.
Discussion
Athetoid movements are rare extraglandular symptoms of pSS.
Current data suggest that choreoathetoid movements associated with
pSS may present in isolation or in combination with neuropsychiatric
symptoms and radiological findings. Evidence also shows that neuro-
logic disease, when present in pSS, can be a strong indicator of disease
activity and morbidity. In these cases, early initiation of treatment has
contributed to good recovery.2
Several theories are available to explain the pathogenesis of
choreoathetoid movements associated with autoimmune disorders.
It is hypothesized that autoantibodies can 1) induce vasculitic changes
in the basal ganglia, 2) inhibit M3 muscarinic receptors in the basal
ganglia, or 3) induce a neuroendocrine–immune imbalance causing
neuronal damage.3 All of these chemical changes may cause dysregu-
lation in the function of the basal ganglia.
A small number of cases reporting autoimmune choreoathetoid
movements are reported in the literature, which we describe below.
The first case reported a 69-year-old male with right limb choreo-
athetosis. Treatment with steroids was not effective; however, the
symptoms resolved after treatment with thioridazine hydrochloride.4
The second case described a 43-year-old female who subacutely
developed chorea and neuropsychiatric symptoms. Her symptoms
improved after a 1-month course of prednisone, 40 mg per day, and
azathioprine, 50 mg per day.5 The third report, described an elderly
male patient with chorea, personality changes, and bilateral basal
ganglia hyperintensities on MRI. His symptoms and radiological
findings completely resolved after 2 months of treatment with oral
prednisolone, 60 mg/day.6 The Mayo Clinic’s 16-year study of adult-
onset autoimmune choreas reported two patients with pSS and two
with combined autoimmune disorders. Choreas improved in only
one patient who was treated with intravenous methylprednisolone
for 5 days.7
Our case highlights the importance of considering autoimmune
disorders as a cause of subacute athetoid movements in elderly
patients. Although aggressive treatment is recommended, treatment
should be individualized to each patient’s needs. The present case
should help physicians raise their clinical suspicion of this disorder in
order to identify, and thus implement, early and appropriate support
and care.
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Video 1. Clinical Characteristics of Involuntary Movements. In the
pre-treatment segment, we can observe the patient at rest and in recumbent
supine position, generalized slow undulating writhing movements of the head,
trunk, pelvis, arms, and legs. Movements have no rhythm, do not follow
a specific pattern, and seem to be flowing from one side to the other. In the
post-treatment 6-month follow-up segment, the patient is in recumbent position
and sitting position, and no movements are observed.
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